Resources

Type of publications
Regions
Diseases
5052 results found
2023 ∙ Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination in children and adolescents in Belgium
Recommendation Europe Belgium Children Adolescents Pneumococcal disease
Download:
2023 ∙ NACI
NACI guidance on COVID-19 vaccine booster doses: Initial considerations for 2023
Recommendation Americas Canada booster dose COVID-19
Download:
2023 ∙ NIAC
Recommendations for COVID-19 vaccination of children aged 6 months to 4 years
Recommendation Europe Ireland Children COVID-19
Download:
2022 ∙ Borra, S. S. Narenthiran, C. K. Kumar, D. Ayilya, M. Sadagoban, G. K.
A Comprehensive Review on Efficacy and Adverse Events Associated With Different Covid-19 Vaccines
Adults Older adults COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Dhanani, Lindsay Y. Franz, Berkeley
A Meta-Analysis of COVID-19 Vaccine Attitudes and Demographic Characteristics in the United States
Americas United States of America Adults Older adults Healthcare workers COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ripon, R. K. Motahara, U. Alam, A. Ishadi, K. S. Sarker, M. S.
A meta-analysis of COVID-19 vaccines acceptance among Black /African American
Americas United States of America All age groups COVID-19 Acceptance Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ashmawy, R. Hamdy, N. A. Elhadi, Y. A. M. Alqutub, S. T. Esmail, O. F. Abdou, M. S. M. Reyad, O. A. El-Ganainy, S. O. Gad, B. K. Nour El-Deen, A. E. Kamal, A. ElSaieh, H. Elrewiny, E. Shaaban, R. Ghazy, R. M.
A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines
Adults Older adults COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Bussink-Voorend, D. Hautvast, J. L. A. Vandeberg, L. Visser, O. Hulscher, Mejl
A systematic literature review to clarify the concept of vaccine hesitancy
All age groups Parents/caregivers Healthcare workers Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ de Abreu, A. J. L. Cavalcante, J. R. de Araújo Lagos, L. W. Caetano, R. Braga, J. U.
A Systematic Review and a Meta-Analysis of the Yellow Fever Vaccine in the Elderly Population
Adults Older adults Yellow fever Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Noori, M. Azizi, S. Abbasi Varaki, F. Nejadghaderi, S. A. Bashash, D.
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Adults Older adults COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...